Vivimed Labs zooms 7.8% after unit successfully completes USFDA inspection

India Infoline News Service | Mumbai | November 30, 2016 15:54 IST

The company’s ‘Finished Dosage Form’ manufacturing facility has had a favourable outcome post its USFDA inspection.

Vivimed Labs Ltd is currently trading at Rs 100, up by Rs 7.65 or 8.28% from its previous closing of Rs 92.35 on the BSE. The company said that the US health regulator has completed the inspection of its manufacturing facility in Alathur. The company’s ‘Finished Dosage Form’ manufacturing facility has had a favourable outcome post its USFDA inspection.

The scrip opened at Rs 104.35 and has touched a high and low of Rs 107.4 and Rs 99 respectively. So far 2458341 (NSE+BSE) shares were traded on the counter. The current market cap of the company is Rs 748.21 crore.

The BSE group 'B' stock of face value Rs 2 has touched a 52 week high of Rs 121.15 on 04-Oct-2016 and a 52 week low of Rs 68 on 09-Aug-2016. Last one week high and low of the scrip stood at Rs 95.9 and Rs 83.5 respectively.

The promoters holding in the company stood at 37.23 % while Institutions and Non-Institutions held 2.87 % and 59.9 % respectively.

The stock is currently trading below its 50 DMA.


***Note: This is a NSE Chart

 

Advertisements

  • Get your free IIFL Demat & Trading A/c now...Click here
  • Get IIFL express personal loan disbursal in just 8* hours...Know More
  • Get the most detailed result analysis on the web - Real Fast!
  • Actionable & Award-Winning Research on 500 Listed Indian Companies.